Trupanion (NASDAQ:TRUP) Given New $57.00 Price Target at Piper Sandler

Trupanion (NASDAQ:TRUPGet Free Report) had its price target upped by investment analysts at Piper Sandler from $45.00 to $57.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a “neutral” rating on the financial services provider’s stock. Piper Sandler’s price objective would suggest a potential upside of 3.28% from the company’s current price.

A number of other research analysts also recently commented on the company. Bank of America increased their target price on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Northland Securities increased their target price on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a report on Thursday, September 19th. Stifel Nicolaus increased their target price on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a report on Monday, September 23rd. Evercore ISI raised Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Finally, William Blair initiated coverage on Trupanion in a report on Friday, July 19th. They set an “outperform” rating on the stock. Four analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $43.83.

Read Our Latest Stock Analysis on Trupanion

Trupanion Price Performance

Trupanion stock traded up $0.07 during trading hours on Thursday, hitting $55.19. The stock had a trading volume of 520,462 shares, compared to its average volume of 679,287. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63. Trupanion has a 1-year low of $19.14 and a 1-year high of $57.90. The stock’s fifty day moving average is $46.73 and its two-hundred day moving average is $35.87. The stock has a market capitalization of $2.32 billion, a price-to-earnings ratio of -86.56 and a beta of 1.73.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The business had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same quarter last year, the firm earned ($0.10) earnings per share. The company’s revenue for the quarter was up 14.6% compared to the same quarter last year. As a group, analysts predict that Trupanion will post -0.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Trupanion

In other news, CFO Fawwad Qureshi sold 640 shares of Trupanion stock in a transaction on Friday, August 16th. The stock was sold at an average price of $43.12, for a total transaction of $27,596.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, CFO Fawwad Qureshi sold 640 shares of Trupanion stock in a transaction on Friday, August 16th. The stock was sold at an average price of $43.12, for a total transaction of $27,596.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares in the company, valued at approximately $4,647,256.32. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,764 shares of company stock valued at $405,238 in the last quarter. Corporate insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Trupanion

A number of hedge funds have recently modified their holdings of the stock. Fernwood Investment Management LLC grew its holdings in shares of Trupanion by 33.3% in the 3rd quarter. Fernwood Investment Management LLC now owns 20,000 shares of the financial services provider’s stock worth $840,000 after acquiring an additional 5,000 shares during the last quarter. OmniStar Financial Group Inc. acquired a new position in shares of Trupanion in the 3rd quarter worth $535,000. GAMMA Investing LLC grew its holdings in shares of Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 596 shares during the last quarter. Handelsbanken Fonder AB acquired a new position in shares of Trupanion in the 3rd quarter worth $248,000. Finally, EP Wealth Advisors LLC acquired a new position in shares of Trupanion in the 2nd quarter worth $294,000.

About Trupanion

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Recommended Stories

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.